Rare diseases
Investigational molecules
Locations
26 Landsdowne Street, 02139-4216, United States
Fulcrum Therapeutics Inc. focuses on clinical research in facioscapulohumeral muscular dystrophy, with studies centered on disease progression, muscle function, and long-term treatment effects in affected individuals.
The company’s research activity in this area is directed toward understanding and addressing the clinical burden of this inherited neuromuscular disorder.
Fulcrum Therapeutics Inc. runs clinical trials in conditions such as Facioscapulohumeral muscular dystrophy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Denmark
France
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
